Literature DB >> 21922313

Dilated cardiomyopathy and inclusion body myositis.

Piercarlo Ballo1, Leandro Chiodi, Matteo Cameli, Alessandro Malandrini, Antonio Federico, Sergio Mondillo, Alfredo Zuppiroli.   

Abstract

Inclusion body myositis (IBM) is the most common inflammatory myopathy after 50 years of age. In contrast to polymyositis and dermatomyositis, in which cardiac involvement is relatively common, current evidences indicate that IBM is not associated with cardiac disease. We report the case of a patient with biopsy-proven IBM who developed heart failure and major ventricular arrhythmias secondary to dilated cardiomyopathy few months after the clinical onset of IBM, and in whom no pathophysiologic causes explaining cardiac enlargement and dysfunction were found by laboratory and instrumental investigations. The hypothesis of a pathophysiologic association between the two conditions is discussed.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21922313     DOI: 10.1007/s10072-011-0766-2

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  11 in total

1.  Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele.

Authors:  V Askanas; W K Engel; R B Alvarez; B Frangione; J Ghiso; R Vidal
Journal:  Ann Neurol       Date:  2000-04       Impact factor: 10.422

Review 2.  Inflammatory myopathies: how to treat the difficult cases.

Authors:  F L Mastaglia; P J Zilko
Journal:  J Clin Neurosci       Date:  2003-01       Impact factor: 1.961

3.  Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis.

Authors:  Merrilee Needham; Alastair Corbett; Timothy Day; Frank Christiansen; Vicki Fabian; Frank L Mastaglia
Journal:  J Clin Neurosci       Date:  2008-09-23       Impact factor: 1.961

4.  Cardiac involvement in sporadic inclusion-body myositis.

Authors:  Wolfgang Utz; Saskia Schmidt; Jeanette Schulz-Menger; Friedrich Luft; Simone Spuler
Journal:  Circulation       Date:  2010-02-09       Impact factor: 29.690

5.  Distal vacuolar myopathy with complete heart block.

Authors:  D A Krendel; J M Gilchrist; E H Bossen
Journal:  Arch Neurol       Date:  1988-06

Review 6.  The heart in dermatomyositis and polymyositis.

Authors:  I E Lundberg
Journal:  Rheumatology (Oxford)       Date:  2006-10       Impact factor: 7.580

7.  The spectrum of GNE mutations: allelic heterogeneity for a common phenotype.

Authors:  Marina Grandis; Rossella Gulli; Denise Cassandrini; Elisabetta Gazzerro; Luana Benedetti; Eleonora Narciso; Lucilla Nobbio; Claudio Bruno; Carlo Minetti; Emilia Bellone; Lizia Reni; Giovanni Luigi Mancardi; Paola Mandich; Angelo Schenone
Journal:  Neurol Sci       Date:  2010-03-19       Impact factor: 3.307

8.  Ventricular tachycardia in a patient with inclusion-body myositis.

Authors:  Jordan M Prutkin; Kristen K Patton
Journal:  Pacing Clin Electrophysiol       Date:  2009-09-10       Impact factor: 1.976

9.  Sporadic inclusion body myositis: phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases.

Authors:  M Needham; I James; A Corbett; T Day; F Christiansen; B Phillips; F L Mastaglia
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-02-07       Impact factor: 10.154

10.  The heart in sporadic inclusion body myositis: a study in 51 patients.

Authors:  Fieke M Cox; Victoria Delgado; Jan J Verschuuren; Bart E Ballieux; Jeroen J Bax; Axel R Wintzen; Umesh A Badrising
Journal:  J Neurol       Date:  2009-10-08       Impact factor: 4.849

View more
  2 in total

1.  ANT1 is reduced in sporadic inclusion body myositis.

Authors:  E Barca; M Aguennouz; A Mazzeo; S Messina; A Toscano; G L Vita; S Portaro; D Parisi; C Rodolico
Journal:  Neurol Sci       Date:  2012-02-21       Impact factor: 3.307

Review 2.  Emerging therapeutic options for sporadic inclusion body myositis.

Authors:  Lindsay N Alfano; Linda P Lowes
Journal:  Ther Clin Risk Manag       Date:  2015-09-25       Impact factor: 2.423

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.